Skip to content

Yubo International Biotech Ltd

YBGJ

CIK 0000895464

← back to feed
Revenue (TTM)
$0
+256.0% YoY Q1 Mar 2026
Net Income (TTM)
−$1.25M
+39.2% YoY Q1 Mar 2026
EPS Diluted (TTM)
$0.00
+50.0% YoY Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
—
Q1 Mar 2026
Net Margin
—
Q1 Mar 2026
Free Cash Flow (TTM)
−$987.58K
Q1 Mar 2026
Cash
$10.38K
Q1 Mar 2026
Total Debt
—
Q1 Mar 2026
Shares Outstanding
170.42M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings